270 related articles for article (PubMed ID: 19001530)
1. A novel role of Shc adaptor proteins in steroid hormone-regulated cancers.
Alam SM; Rajendran M; Ouyang S; Veeramani S; Zhang L; Lin MF
Endocr Relat Cancer; 2009 Mar; 16(1):1-16. PubMed ID: 19001530
[TBL] [Abstract][Full Text] [Related]
2. p66Shc protein is upregulated by steroid hormones in hormone-sensitive cancer cells and in primary prostate carcinomas.
Lee MS; Igawa T; Chen SJ; Van Bemmel D; Lin JS; Lin FF; Johansson SL; Christman JK; Lin MF
Int J Cancer; 2004 Feb; 108(5):672-8. PubMed ID: 14696093
[TBL] [Abstract][Full Text] [Related]
3. Expression of p66(Shc) protein correlates with proliferation of human prostate cancer cells.
Veeramani S; Igawa T; Yuan TC; Lin FF; Lee MS; Lin JS; Johansson SL; Lin MF
Oncogene; 2005 Nov; 24(48):7203-12. PubMed ID: 16170380
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine-317 of p52(Shc) mediates androgen-stimulated proliferation signals in human prostate cancer cells.
Lee MS; Igawa T; Lin MF
Oncogene; 2004 Apr; 23(17):3048-58. PubMed ID: 14990987
[TBL] [Abstract][Full Text] [Related]
5. Downregulated adaptor protein p66(Shc) mitigates autophagy process by low nutrient and enhances apoptotic resistance in human lung adenocarcinoma A549 cells.
Zheng Z; Yang J; Zhao D; Gao D; Yan X; Yao Z; Liu Z; Ma Z
FEBS J; 2013 Sep; 280(18):4522-30. PubMed ID: 23815759
[TBL] [Abstract][Full Text] [Related]
6. Constitutively tyrosine phosphorylated p52 Shc in breast cancer cells: correlation with ErbB2 and p66 Shc expression.
Stevenson LE; Frackelton AR
Breast Cancer Res Treat; 1998 May; 49(2):119-28. PubMed ID: 9696394
[TBL] [Abstract][Full Text] [Related]
7. Adaptor protein Shc undergoes translocation and mediates up-regulation of the tyrosine kinase c-Src in EGF-stimulated A431 cells.
Sato K; Kimoto M; Kakumoto M; Horiuchi D; Iwasaki T; Tokmakov AA; Fukami Y
Genes Cells; 2000 Sep; 5(9):749-64. PubMed ID: 10971656
[TBL] [Abstract][Full Text] [Related]
8. The p66(Shc) redox adaptor protein is induced by saturated fatty acids and mediates lipotoxicity-induced apoptosis in pancreatic beta cells.
Natalicchio A; Tortosa F; Labarbuta R; Biondi G; Marrano N; Carchia E; Leonardini A; Cignarelli A; Bugliani M; Marchetti P; Fadini GP; Giorgio M; Avogaro A; Perrini S; Laviola L; Giorgino F
Diabetologia; 2015 Jun; 58(6):1260-71. PubMed ID: 25810038
[TBL] [Abstract][Full Text] [Related]
9. The longevity protein p66
Huang C; Ding T; Zhang Y; Li X; Sun X; Lv S; Hao Y; Bai L; Liu N; Xie Y; Chen H; Nie Y
J Mol Cell Cardiol; 2023 Apr; 177():21-27. PubMed ID: 36827872
[TBL] [Abstract][Full Text] [Related]
10. c-Src and phosphatidylinositol 3-kinase are involved in NGF-dependent tyrosine phosphorylation of Shc in PC12 cells.
Sato K; Otsuki T; Kimoto M; Kakumoto M; Tokmakov AA; Watanabe Y; Fukami Y
Biochem Biophys Res Commun; 1998 Sep; 250(2):223-8. PubMed ID: 9753611
[TBL] [Abstract][Full Text] [Related]
11. Agonist-mediated tyrosine phosphorylation of isoforms of the shc adapter protein by the delta opioid receptor.
Mullaney I; Carr IC; Burt AR; Wilson M; Anderson NG; Milligan G
Cell Signal; 1997 Sep; 9(6):423-9. PubMed ID: 9376223
[TBL] [Abstract][Full Text] [Related]
12. Endothelin-1 induces serine phosphorylation of the adaptor protein p66Shc and its association with 14-3-3 protein in glomerular mesangial cells.
Foschi M; Franchi F; Han J; La Villa G; Sorokin A
J Biol Chem; 2001 Jul; 276(28):26640-7. PubMed ID: 11342545
[TBL] [Abstract][Full Text] [Related]
13. The silence of p66(Shc) in HCT8 cells inhibits the viability via PI3K/AKT/Mdm-2/p53 signaling pathway.
Zhang L; Zhu S; Shi X; Sha W
Int J Clin Exp Pathol; 2015; 8(8):9097-104. PubMed ID: 26464652
[TBL] [Abstract][Full Text] [Related]
14. Serine/threonine phosphorylation of ShcA. Regulation of protein-tyrosine phosphatase-pest binding and involvement in insulin signaling.
Faisal A; el-Shemerly M; Hess D; Nagamine Y
J Biol Chem; 2002 Aug; 277(33):30144-52. PubMed ID: 12052829
[TBL] [Abstract][Full Text] [Related]
15. p66Shc--a longevity redox protein in human prostate cancer progression and metastasis : p66Shc in cancer progression and metastasis.
Rajendran M; Thomes P; Zhang L; Veeramani S; Lin MF
Cancer Metastasis Rev; 2010 Mar; 29(1):207-22. PubMed ID: 20111892
[TBL] [Abstract][Full Text] [Related]
16. Insulin receptor substrate 2 and Shc play different roles in insulin-like growth factor I signaling.
Kim B; Cheng HL; Margolis B; Feldman EL
J Biol Chem; 1998 Dec; 273(51):34543-50. PubMed ID: 9852124
[TBL] [Abstract][Full Text] [Related]
17. Adaptor protein p66(Shc) mediates hypertension-associated, cyclic stretch-dependent, endothelial damage.
Spescha RD; Glanzmann M; Simic B; Witassek F; Keller S; Akhmedov A; Tanner FC; Lüscher TF; Camici GG
Hypertension; 2014 Aug; 64(2):347-53. PubMed ID: 24842918
[TBL] [Abstract][Full Text] [Related]
18. Multiple Grb2-mediated integrin-stimulated signaling pathways to ERK2/mitogen-activated protein kinase: summation of both c-Src- and focal adhesion kinase-initiated tyrosine phosphorylation events.
Schlaepfer DD; Jones KC; Hunter T
Mol Cell Biol; 1998 May; 18(5):2571-85. PubMed ID: 9566877
[TBL] [Abstract][Full Text] [Related]
19. p66shc inhibits pro-survival epidermal growth factor receptor/ERK signaling during severe oxidative stress in mouse renal proximal tubule cells.
Arany I; Faisal A; Nagamine Y; Safirstein RL
J Biol Chem; 2008 Mar; 283(10):6110-7. PubMed ID: 18174162
[TBL] [Abstract][Full Text] [Related]
20. Enhanced expression of adaptor molecule p46 Shc in nuclei of hepatocellular carcinoma cells: study of LEC rats.
Yoshida S; Masaki T; Feng H; Yuji J; Miyauchi Y; Funaki T; Yoshiji H; Matsumoto K; Uchida N; Watanabe S; Kurokohchi K; Kuriyama S
Int J Oncol; 2004 Oct; 25(4):1089-96. PubMed ID: 15375560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
